Skip to content
MedsAcross

Brand family

Cobenfy

Trospium and Xanomeline · ER Squibb & Sons
United States
Presentations
4
Markets
1

Cobenfy is a brand of Trospium and Xanomeline marketed by ER Squibb & Sons, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Trospium and Xanomeline
Brand owner
ER Squibb & Sons
Registered in
United States
Strengths and forms
20 mg/100 mg capsule, 20 mg/50 mg capsule, 30 mg/125 mg capsule, kit

All presentations

MedicineManufacturerRegisterAvailability
Cobenfy 20 mg/100 mg capsuleOralER Squibb & SonsUS FDAAvailable on request
Cobenfy 20 mg/50 mg capsuleOralER Squibb & SonsUS FDAAvailable on request
Cobenfy 30 mg/125 mg capsuleOralER Squibb & SonsUS FDAAvailable on request
Cobenfy kitER Squibb & SonsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Cobenfy

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.